Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences, Inc. (FBRX) Total Liabilities (2016 - 2020)

Forte Biosciences (FBRX) has disclosed Total Liabilities for 5 consecutive years, with $2.4 million as the latest value for Q3 2020.

  • On a quarterly basis, Total Liabilities fell 95.27% to $2.4 million in Q3 2020 year-over-year; TTM through Sep 2020 was $2.4 million, a 95.27% decrease, with the full-year FY2019 number at $17.3 million, down 61.47% from a year prior.
  • Total Liabilities was $2.4 million for Q3 2020 at Forte Biosciences, down from $3.4 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $50.9 million in Q3 2019 to a low of $2.4 million in Q3 2020.
  • A 5-year average of $29.2 million and a median of $25.3 million in 2016 define the central range for Total Liabilities.
  • Peak YoY movement for Total Liabilities: soared 161.65% in 2019, then crashed 95.27% in 2020.
  • Forte Biosciences' Total Liabilities stood at $28.4 million in 2016, then decreased by 25.97% to $21.0 million in 2017, then skyrocketed by 114.07% to $44.9 million in 2018, then tumbled by 61.47% to $17.3 million in 2019, then tumbled by 86.07% to $2.4 million in 2020.
  • Per Business Quant, the three most recent readings for FBRX's Total Liabilities are $2.4 million (Q3 2020), $3.4 million (Q2 2020), and $16.6 million (Q1 2020).